IL107066A - Pharmaceutical preparations containing oligomers of sodium salts of diaminobenzendisulfonic acid for resistance against inositol 1,4,5-triphosphate - Google Patents

Pharmaceutical preparations containing oligomers of sodium salts of diaminobenzendisulfonic acid for resistance against inositol 1,4,5-triphosphate

Info

Publication number
IL107066A
IL107066A IL107066A IL10706693A IL107066A IL 107066 A IL107066 A IL 107066A IL 107066 A IL107066 A IL 107066A IL 10706693 A IL10706693 A IL 10706693A IL 107066 A IL107066 A IL 107066A
Authority
IL
Israel
Prior art keywords
inositol
triphosphate
oligomers
pharmaceutical compositions
antagonizing
Prior art date
Application number
IL107066A
Other languages
English (en)
Hebrew (he)
Other versions
IL107066A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL107066A0 publication Critical patent/IL107066A0/xx
Publication of IL107066A publication Critical patent/IL107066A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL107066A 1992-09-28 1993-09-22 Pharmaceutical preparations containing oligomers of sodium salts of diaminobenzendisulfonic acid for resistance against inositol 1,4,5-triphosphate IL107066A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95239392A 1992-09-28 1992-09-28

Publications (2)

Publication Number Publication Date
IL107066A0 IL107066A0 (en) 1993-12-28
IL107066A true IL107066A (en) 1998-01-04

Family

ID=25492868

Family Applications (1)

Application Number Title Priority Date Filing Date
IL107066A IL107066A (en) 1992-09-28 1993-09-22 Pharmaceutical preparations containing oligomers of sodium salts of diaminobenzendisulfonic acid for resistance against inositol 1,4,5-triphosphate

Country Status (13)

Country Link
EP (1) EP0661982A1 (zh)
JP (1) JPH08502068A (zh)
KR (1) KR950703347A (zh)
AU (1) AU670962B2 (zh)
CA (1) CA2145681A1 (zh)
HU (1) HUT70192A (zh)
IL (1) IL107066A (zh)
MX (1) MX9305933A (zh)
NO (1) NO951163L (zh)
NZ (1) NZ256178A (zh)
TW (1) TW260663B (zh)
WO (1) WO1994007507A1 (zh)
ZA (1) ZA936978B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2978995A (en) * 1994-06-30 1996-01-25 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Methods for treating cell proliferative disorders by modulating signal transduction
EP0809492A4 (en) 1995-02-17 2007-01-24 Smithkline Beecham Corp IL-8 RECEPTOR ANTAGONISTS
US5780483A (en) * 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists
US6083920A (en) * 1995-12-21 2000-07-04 Ayurcore, Inc. Compositions for modulating intracellular inositol trisphosphate concentration
US6005008A (en) * 1996-02-16 1999-12-21 Smithkline Beecham Corporation IL-8 receptor antagonists
US6211373B1 (en) 1996-03-20 2001-04-03 Smithkline Beecham Corporation Phenyl urea antagonists of the IL-8 receptor
US6262113B1 (en) 1996-03-20 2001-07-17 Smithkline Beecham Corporation IL-8 receptor antagonists
US6133319A (en) * 1996-06-27 2000-10-17 Smithkline Beecham Corporation IL-8 receptor antagonists
EP0915651A4 (en) 1996-06-27 2001-10-24 Smithkline Beecham Corp IL-8 RECEPTOR ANTAGONISTS
ATE358486T1 (de) * 2000-11-09 2007-04-15 Contrimmune Biotechnology Inc Verwendung von xestospongin c zur behandlung oder vorbeugung einer hiv-infektion
JP2014531425A (ja) 2011-09-02 2014-11-27 ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク 肥満の代謝異常を治療するためのＣａＭＫＩＩ、ＩＰ３Ｒ、カルシニューリン、ｐ３８、およびＭＫ２／３阻害剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers

Also Published As

Publication number Publication date
IL107066A0 (en) 1993-12-28
ZA936978B (en) 1994-04-18
NO951163D0 (no) 1995-03-27
JPH08502068A (ja) 1996-03-05
CA2145681A1 (en) 1994-04-14
WO1994007507A1 (en) 1994-04-14
MX9305933A (es) 1994-04-29
AU4841793A (en) 1994-04-26
HU9500891D0 (en) 1995-05-29
EP0661982A1 (en) 1995-07-12
HUT70192A (en) 1995-09-28
TW260663B (zh) 1995-10-21
KR950703347A (ko) 1995-09-20
AU670962B2 (en) 1996-08-08
NO951163L (no) 1995-03-27
NZ256178A (en) 1997-03-24

Similar Documents

Publication Publication Date Title
Silveira et al. Putative M2 muscarinic receptors of rat heart have high affinity for organophosphorus anticholinesterases
Arnt et al. Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI
McCarthy et al. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications
Akera Membrane Adenosinetriphosphatase: A Digitalis Receptor? The enzyme is a good model for receptor binding studies because of its known functional correlates.
Schrör The pharmacology of cilostazol
US7501436B2 (en) 5-HT3 receptor antagonists and methods of use
US5204329A (en) Treatment of organ transplantation rejection
US20040006120A1 (en) Use of histamine h3 receptor inverse agonists for the control of appetite and treatment of obesity
IL107066A (en) Pharmaceutical preparations containing oligomers of sodium salts of diaminobenzendisulfonic acid for resistance against inositol 1,4,5-triphosphate
CA2194277A1 (en) Canptothecin drug combinations and medicaments with reduced side effects
Allison et al. Inhibition of the effect of lithium on brain inositol by atropine and scopolamine
US20050043327A1 (en) Pharmaceutical composition for the prevention and treatment of addiction in a mammal
TW201922246A (zh) 以ccr2拮抗劑治療局部性腎絲球硬化症
Chakravarty et al. A highly potent, orally active imidazo [4, 5-b] pyridine biphenyl acylsulfonamide (MK-996; L-159,282): A new AT1-selective angiotensin II receptor antagonist
JPH07502737A (ja) 複素環式化合物およびそれらの製法並びに使用
Ahlijanian et al. Antagonism of calmodulin-stimulated adenylate cyclase by trifluoperazine, calmidazolium and W-7 in rat cerebellar membranes.
JP2565762B2 (ja) グルカゴン同族体の合成とその治療用途
PT1560830E (pt) Derivados de [6, 7-di-hidro-5h-imidazo-[1, 2-a] imidazole-3-sulfonilamino]-propionamida e a sua utilização como inibidores da interacção de cams e leucointegrinas
US20030008848A1 (en) Small molecules useful in the treatment of inflammatory disease
Way Opioid tolerance and physical dependence and their relationship
CA3005961A1 (en) An a3 adenosine receptor ligand for use in treating ectopic fat accumulation
JP2003512607A (ja) ムスカリン受容体のアロステリック部位
McQuade et al. Characterization of the radioiodinated analogue of SCH 23390: in vitro and in vivo D-1 dopamine receptor binding studies
Liebmann et al. Pharmacological and molecular actions of the bradykinin B2 receptor antagonist, Hoe 140, in the rat uterus
US20030232817A1 (en) Small molecules useful for the treatment of inflammatory disease

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void